Evidence map›Paper›PMID 39162508›Full record

ArticleMicrobiology spectrum2024

Three prolonged outbreaks of metallo-β-lactamase-producing

Adriana Cabal, Anna Hörtenhuber, Yarub Salaheddin, Anna Stöger, Burkhard Springer, Stefan Bletz, Alexander Mellmann, Patrick Hyden, Rainer Hartl, Johannes Weinberger and 7 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Characterization ofFrontiers in veterinary science · 2026
    Article
  3. Article
  4. New resistance threat in difficult-to-treat resistanceEmerging microbes & infections · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Adriana CabalDivision for Public Health, Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Vienna, Austria.ORCID 0000-0001-9346-1612
Anna HörtenhuberInstitute of Pathology, Upper Austrian Health Holding GmbH, Pyhrn-Eisenwurzen Clinical Centre Kirchdorf Steyr, Steyr, Austria.
Yarub SalaheddinInstitute of Pathology, Upper Austrian Health Holding GmbH, Pyhrn-Eisenwurzen Clinical Centre Kirchdorf Steyr, Steyr, Austria.
Anna StögerDivision for Public Health, Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Vienna, Austria.
Burkhard SpringerDivision for Public Health, Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Graz, Austria.
Stefan BletzInstitute of Hygiene, University Hospital Muenster and University of Muenster, Muenster, Germany.
Alexander MellmannInstitute of Hygiene, University Hospital Muenster and University of Muenster, Muenster, Germany.
Patrick HydenDepartment of Statistics and Analytical Epidemiology, Austrian Agency for Health and Food Safety, Vienna, Austria.
Rainer HartlNational Reference Center for Antimicrobial Resistance, Institute for Hygiene, Microbiology and Tropical Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria.
Johannes WeinbergerAres Genetics GmbH, Vienna, Austria.
Rick ConzemiusAres Genetics GmbH, Vienna, Austria.
Markus HellMEDILAB, Teaching Laboratory of the Paracelsus Medical University, Salzburg, Austria.
Beatriz Daza-PrietoDivision for Public Health, Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Vienna, Austria.ORCID 0000-0002-7138-5441
Kathrin LippertDivision for Public Health, Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Vienna, Austria.
Georg SteindlInstitute for Hospital Hygiene and Microbiology (IKM), Graz, Austria.
Sandra Köberl-JelovcanDivision for Public Health, Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Graz, Austria.
Werner RuppitschDivision for Public Health, Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Vienna, Austria.ORCID 0000-0001-9940-3333

Funding

EU4Health Programme 101102440
6 · The paper itself

Abstract

In spring 2022, an increase in metallo-β-lactamase-producing IMPORTANCE: The significance of our work lies in the successful resolution of three prolonged outbreaks of MBL-Pa infections in a hospital in Upper Austria. Through a comprehensive epidemiological investigation coupled with WGS-based typing of

Indexed as

beta-LactamasesCross InfectionDisease OutbreaksMultilocus Sequence TypingPseudomonas aeruginosaPseudomonas InfectionsWhole Genome SequencingAdultAgedAnti-Bacterial AgentsAustriaFemaleHospitalsHumansIntensive Care UnitsMaleAnti-Bacterial Agentsbeta-LactamasesAustriacgMLSTmetallo-β-lactamaseoutbreakPseudomonas aeruginosa

Identifiers

PMID39162508
PMCPMC11448029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.